Hard NAPLEX Adverse Drug Reaction Practice Questions

Concept Explanation

An adverse drug reaction (ADR) is any unintended, harmful, or noxious response to a medication that occurs at doses normally used in humans for prophylaxis, diagnosis, or therapy. Understanding these reactions is a critical component of NAPLEX Prep, as pharmacists must distinguish between predictable side effects and life-threatening immunological responses. ADRs are generally categorized using the Rawlins and Thompson classification into Type A (Augmented) and Type B (Bizarre) reactions. Type A reactions are dose-dependent, predictable based on the drug's pharmacology, and account for 80% of cases. Type B reactions are idiosyncratic, non-dose-dependent, and often involve hypersensitivity or genetic predispositions, such as Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN).

Clinical management of ADRs requires familiarity with the Naranjo Algorithm, a validated tool used to determine the probability that a specific drug caused an adverse event. Furthermore, specific genetic markers, such as $HLA-B*5701$ for abacavir or $HLA-B*1502$ for carbamazepine, are tested to mitigate the risk of severe cutaneous adverse reactions (SCARs). Pharmacists are also responsible for reporting serious ADRs to the FDA MedWatch program to ensure ongoing post-marketing surveillance.

Solved Examples

1. Naranjo Scale Calculation: A patient develops a rash after starting amoxicillin. The rash subsided when the drug was discontinued (+1). The reaction reappeared when the drug was accidentally restarted (+2). The reaction is a recognized effect of the drug (+1). There were no alternative causes (+2). Calculate the Naranjo score and determine the probability.
   1. Identify the individual scores: $1 + 2 + 1 + 2 = 6$.
   2. Apply the Naranjo interpretation: 0 = Doubtful; 1–4 = Possible; 5–8 = Probable; \u2265 9 = Definite.
   3. Conclusion: A score of 6 indicates a Probable adverse drug reaction.
2. Genetic Screening for SCARs: A patient of Han Chinese descent is about to start carbamazepine for trigeminal neuralgia. Why is genetic testing mandatory?
   1. Identify the high-risk allele: $HLA-B*1502$.
   2. Understand the consequence: This allele is strongly associated with SJS/TEN in certain Asian populations.
   3. Clinical Action: If the test is positive, carbamazepine should be avoided unless the benefit clearly outweighs the risk.
3. Type I vs. Type IV Hypersensitivity: Differentiate between an immediate penicillin allergy and a delayed-onset rash.
   1. Type I: IgE-mediated, occurs within minutes to hours, characterized by hives, angioedema, or anaphylaxis.
   2. Type IV: T-cell mediated, occurs days to weeks later, characterized by maculopapular eruptions or SJS.
   3. Management: Type I requires permanent avoidance of the class; Type IV may allow for graded challenges depending on severity.

Practice Questions

1. A 34-year-old male with HIV is being screened before starting a new antiretroviral regimen. The physician wants to prescribe abacavir. Which genetic marker must be negative to safely initiate this medication?

2. A patient taking clozapine for treatment-resistant schizophrenia presents with a white blood cell (WBC) count of $1,800 \text{ cells/mm}^3$ and an absolute neutrophil count (ANC) of $900 \text{ cells/mm}^3$. According to the Clozapine REMS program, what is the required clinical action?

3. A patient is prescribed allopurinol for gout prophylaxis. The pharmacist notes the patient is of Korean descent with Stage 3 Chronic Kidney Disease. Which specific allele testing should be considered to prevent severe hypersensitivity syndrome?

4. Contrast the clinical presentation of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) based on the percentage of body surface area (BSA) detachment.

5. A patient receiving an intravenous infusion of vancomycin at a rate of $1,500 \text{ mg}$ over 30 minutes develops intense flushing and pruritus on the face and neck. What is the mechanism of this reaction, and how should it be managed?

6. An elderly patient is taking amiodarone for atrial fibrillation. During a follow-up visit, the patient complains of a blue-grey skin discoloration in sun-exposed areas. Is this a Type A or Type B reaction, and is it reversible?

7. A patient with a history of a "swollen throat and difficulty breathing" after taking lisinopril is now being treated for hypertension. Which medication class should be avoided to prevent a cross-reactive ADR? (Hint: See Hard NAPLEX Hypertension Case Practice Questions for context on ACEi alternatives).

8. A patient experiences a dystonic reaction after receiving a dose of prochlorperazine. Which neurotransmitter imbalance causes this ADR, and what is the first-line pharmacological reversal agent?

9. A patient on warfarin therapy is started on amiodarone. Three days later, the INR increases from 2.2 to 4.5. Is this considered an ADR, and what is the pharmacokinetic mechanism involved?

10. Explain the "Red Alert" criteria for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome compared to a simple drug-induced morbilliform rash.

Answers & Explanations

1. Answer: $HLA-B*5701$. Abacavir hypersensitivity is strongly linked to this allele. Testing is required by the CDC and FDA guidelines before initiation to prevent fatal multi-organ failure.
2. Answer: Discontinue clozapine and monitor closely. An ANC below $1,000 \text{ cells/mm}^3$ is classified as severe neutropenia. The medication must be stopped, and the patient may only be rechallenged if the benefits outweigh the risks and the ANC recovers.
3. Answer: $HLA-B*5801$. This allele is associated with allopurinol hypersensitivity syndrome, especially in patients of Han Chinese, Korean, or Thai descent with underlying renal impairment.
4. Answer: SJS < 10% BSA; TEN > 30% BSA. Reactions involving 10-30% BSA are considered SJS/TEN overlap. Both are medical emergencies requiring immediate drug cessation.
5. Answer: Non-immunologic histamine release (Vancomycin Flushing Syndrome). This is not a true allergy. It is managed by slowing the infusion rate to no more than $10 \text{ mg/min}$ or $1 \text{ gram/hour}$.
6. Answer: Type A (Augmented/Dose-related). While often slow to resolve, the blue-grey pigmentation is a known side effect of long-term amiodarone use and is generally considered slowly reversible or permanent.
7. Answer: ARBs (Angiotensin Receptor Blockers) and Sacubitril/Valsartan. While the risk of cross-reactivity between ACE inhibitors and ARBs for angioedema is low (<10%), caution is required. Sacubitril/Valsartan is strictly contraindicated in patients with a history of ACEi-induced angioedema.
8. Answer: Dopamine-Acetylcholine imbalance. Blockade of D2 receptors in the nigrostriatal pathway leads to excess cholinergic activity. The treatment is an anticholinergic like benztropine or diphenhydramine.
9. Answer: Yes, it is a Type A ADR (drug interaction). Amiodarone inhibits CYP2C9, which is the primary enzyme responsible for metabolizing the more potent S-enantiomer of warfarin. Patients should consult Hard NAPLEX Anticoagulation Practice Questions for more on warfarin management.
10. Answer: Systemic involvement and timing. DRESS typically occurs 2-8 weeks after drug initiation and includes fever, lymphadenopathy, and organ dysfunction (e.g., hepatitis), whereas a morbilliform rash is usually localized to the skin and lacks systemic symptoms.

1. Which of the following is a characteristic of a Type B (Bizarre) adverse drug reaction?

• APredictable from known pharmacology
• BDose-dependent
• CNot related to the pharmacological action of the drug
• DHigh incidence in the general population

Frequently Asked Questions

What is the difference between a side effect and an adverse drug reaction?

A side effect is a predictable, often unavoidable secondary effect produced at standard therapeutic doses, whereas an adverse drug reaction is a more harmful, unintended, and sometimes unpredictable response. Side effects like drowsiness from diphenhydramine are expected, while an ADR like anaphylaxis is a pathological response.

How are Type A and Type B ADRs distinguished?

Type A reactions are augmented responses that are dose-related and predictable based on the drug's mechanism, such as hypoglycemia from insulin. Type B reactions are bizarre, idiosyncratic, not dose-related, and often involve immune-mediated hypersensitivity, such as a rash from sulfonamides.

What should a pharmacist do if they suspect a serious ADR?

The pharmacist should immediately ensure the patient's safety by recommending discontinuation of the offending agent and providing supportive care. Subsequently, the reaction should be reported to the FDA MedWatch program to assist in national safety monitoring.

Are all drug allergies considered ADRs?

Yes, all drug allergies are a subset of adverse drug reactions, specifically falling under Type B reactions. However, not all ADRs are allergies; for example, a toxic effect like nephrotoxicity from aminoglycosides is an ADR but not an immune-mediated allergy.

What is the role of the REMS program in ADR prevention?

Risk Evaluation and Mitigation Strategies (REMS) are safety programs required by the FDA for certain medications with high risks. They ensure that the benefits of a drug outweigh its risks by mandating specific provider training, patient registries, or laboratory monitoring, such as the ANC monitoring for clozapine.

Can a patient be allergic to a drug but not its entire class?

In some cases, yes, though cross-reactivity is common within chemical classes like penicillins or sulfonamides. Pharmacists use structural similarities and clinical data to determine if a patient can safely use a related medication, often utilizing the AI Question Generator to practice these complex clinical scenarios.